Annuncio • Jun 30
Sokan New Materials Group Co., Ltd. to Report First Half, 2026 Results on Aug 29, 2026 Sokan New Materials Group Co., Ltd. announced that they will report first half, 2026 results on Aug 29, 2026 Annuncio • Apr 24
Sokan New Materials Group Co., Ltd. announced that it expects to receive CNY 300 million in funding Sokan New Materials Group Co., Ltd. announced a private placement of not more than 30% of total share capital of A Shares at a price per share of not less than 80% of the average price in the 20 trading days before the pricing reference date to raise gross proceeds of not more than CNY 300,000,000 on April 22, 2026. The transaction involves participation from not more than 35 investors. The transaction has been approved at the 12th Meeting of the 3rd Directorate and is subject to obtain approval from the Company’s Annual Shareholders Meeting of 2025. The shares cannot be transferred within 6 months from the issuance closing date. Reported Earnings • Apr 24
First quarter 2026 earnings released: CN¥0.04 loss per share (vs CN¥0.021 profit in 1Q 2025) First quarter 2026 results: CN¥0.04 loss per share (down from CN¥0.021 profit in 1Q 2025). Revenue: CN¥125.0m (down 18% from 1Q 2025). Net loss: CN¥6.84m (down 280% from profit in 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Annuncio • Apr 24
Sokan New Materials Group Co., Ltd., Annual General Meeting, May 14, 2026 Sokan New Materials Group Co., Ltd., Annual General Meeting, May 14, 2026, at 14:00 China Standard Time. Location: 2F, Kechuang Building, No. 777, Sanhuan North Road, Ningxiang Economic and Technological Development Zone, Hunan China New Risk • Apr 09
New major risk - Revenue and earnings growth Earnings have declined by 10% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 10% per year over the past 5 years. Minor Risk Profit margins are more than 30% lower than last year (3.0% net profit margin). Annuncio • Mar 30
Sokan New Materials Group Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026 Sokan New Materials Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026 Annuncio • Dec 26
Sokan New Materials Group Co., Ltd. to Report Fiscal Year 2025 Results on Apr 24, 2026 Sokan New Materials Group Co., Ltd. announced that they will report fiscal year 2025 results on Apr 24, 2026 Reported Earnings • Oct 31
Third quarter 2025 earnings released: EPS: CN¥0.081 (vs CN¥0.19 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.081 (down from CN¥0.19 in 3Q 2024). Revenue: CN¥205.9m (up 1.2% from 3Q 2024). Net income: CN¥12.9m (down 58% from 3Q 2024). Profit margin: 6.3% (down from 15% in 3Q 2024). Revenue is forecast to grow 33% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has fallen by 15% per year, which means it is performing significantly worse than earnings. Annuncio • Sep 30
Sokan New Materials Group Co., Ltd. to Report Q3, 2025 Results on Oct 31, 2025 Sokan New Materials Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025 Major Estimate Revision • Sep 10
Consensus EPS estimates fall by 27% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥993.5m to CN¥969.0m. EPS estimate also fell from CN¥0.905 per share to CN¥0.66 per share. Net income forecast to grow 124% next year vs 50% growth forecast for Chemicals industry in China. Consensus price target up from CN¥42.14 to CN¥51.00. Share price rose 2.8% to CN¥41.53 over the past week. Reported Earnings • Sep 03
Second quarter 2025 earnings released: EPS: CN¥0.19 (vs CN¥0.19 in 2Q 2024) Second quarter 2025 results: EPS: CN¥0.19 (in line with 2Q 2024). Revenue: CN¥194.4m (up 3.3% from 2Q 2024). Net income: CN¥8.47m (down 70% from 2Q 2024). Profit margin: 4.4% (down from 15% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 31% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 10% per year, which means it is performing significantly worse than earnings. New Risk • Aug 26
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Aug 03
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to CN¥37.01, the stock trades at a forward P/E ratio of 38x. Average forward P/E is 22x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years. Valuation Update With 7 Day Price Move • Jul 16
Investor sentiment deteriorates as stock falls 25% After last week's 25% share price decline to CN¥29.86, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 22x in the Chemicals industry in China. Total loss to shareholders of 59% over the past three years. Annuncio • Jun 30
Sokan New Materials Group Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025 Sokan New Materials Group Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025 Price Target Changed • May 27
Price target increased by 8.9% to CN¥59.00 Up from CN¥54.16, the current price target is provided by 1 analyst. New target price is 53% above last closing price of CN¥38.63. Stock is up 22% over the past year. The company is forecast to post earnings per share of CN¥1.03 for next year compared to CN¥0.78 last year. Major Estimate Revision • May 06
Consensus EPS estimates fall by 16% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from CN¥1.38 to CN¥1.16 per share. Revenue forecast steady at CN¥1.02b. Net income forecast to grow 82% next year vs 42% growth forecast for Chemicals industry in China. Consensus price target of CN¥52.72 unchanged from last update. Share price rose 3.6% to CN¥42.02 over the past week. New Risk • May 03
New major risk - Revenue and earnings growth Earnings have declined by 2.3% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Annuncio • Apr 29
Sokan New Materials Group Co., Ltd., Annual General Meeting, May 20, 2025 Sokan New Materials Group Co., Ltd., Annual General Meeting, May 20, 2025, at 14:00 China Standard Time. Annuncio • Mar 28
Sokan New Materials Group Co., Ltd. to Report Q1, 2025 Results on Apr 29, 2025 Sokan New Materials Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025 Reported Earnings • Feb 26
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: CN¥0.80 (up from CN¥0.73 in FY 2023). Revenue: CN¥748.4m (up 27% from FY 2023). Net income: CN¥89.1m (up 9.9% from FY 2023). Profit margin: 12% (down from 14% in FY 2023). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) also missed analyst estimates by 21%. Revenue is forecast to grow 29% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 19% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • Feb 24
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥43.77, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 21x in the Chemicals industry in China. Total loss to shareholders of 43% over the past three years. Annuncio • Dec 27
Sokan New Materials Group Co., Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025 Sokan New Materials Group Co., Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025 Reported Earnings • Oct 18
Third quarter 2024 earnings released: EPS: CN¥0.27 (vs CN¥0.24 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.27 (up from CN¥0.24 in 3Q 2023). Revenue: CN¥203.5m (up 20% from 3Q 2023). Net income: CN¥30.5m (up 14% from 3Q 2023). Profit margin: 15% (in line with 3Q 2023). Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 11% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥40.81, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 32% over the past three years. Annuncio • Sep 30
Sokan New Materials Group Co., Ltd. to Report Q3, 2024 Results on Oct 18, 2024 Sokan New Materials Group Co., Ltd. announced that they will report Q3, 2024 results on Oct 18, 2024 Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to CN¥45.24, the stock trades at a forward P/E ratio of 38x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 27% over the past three years. New Risk • Sep 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (33% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (6.8% average weekly change). Reported Earnings • Aug 16
Second quarter 2024 earnings released: EPS: CN¥0.26 (vs CN¥0.20 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.26 (up from CN¥0.20 in 2Q 2023). Revenue: CN¥188.1m (up 24% from 2Q 2023). Net income: CN¥28.6m (up 21% from 2Q 2023). Profit margin: 15% (in line with 2Q 2023). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 22% per year, which means it is performing significantly worse than earnings. Annuncio • Jun 29
Sokan New Materials Group Co., Ltd. to Report First Half, 2024 Results on Aug 16, 2024 Sokan New Materials Group Co., Ltd. announced that they will report first half, 2024 results on Aug 16, 2024 Price Target Changed • May 10
Price target decreased by 11% to CN¥71.33 Down from CN¥80.33, the current price target is an average from 2 analysts. New target price is 106% above last closing price of CN¥34.60. Stock is down 34% over the past year. The company is forecast to post earnings per share of CN¥1.18 for next year compared to CN¥0.73 last year. Valuation Update With 7 Day Price Move • May 07
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥38.15, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 42% over the past three years. Annuncio • Apr 27
Hunan Sokan New Materials Co., Ltd., Annual General Meeting, May 17, 2024 Hunan Sokan New Materials Co., Ltd., Annual General Meeting, May 17, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Ningxiang Economic and Technological Development Zone, Hunan China Reported Earnings • Apr 26
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: CN¥0.73 (down from CN¥0.75 in FY 2022). Revenue: CN¥589.8m (up 18% from FY 2022). Net income: CN¥81.1m (down 1.4% from FY 2022). Profit margin: 14% (down from 17% in FY 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 2.5%. Earnings per share (EPS) also missed analyst estimates by 6.1%. Revenue is forecast to grow 33% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 18% per year, which means it is performing significantly worse than earnings. Annuncio • Mar 29
Hunan Sokan New Materials Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024 Hunan Sokan New Materials Co., Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024 Annuncio • Mar 27
Hunan Sokan New Materials Co., Ltd. (SHSE:688157) agreed to acquire 20% stake in Changsha Songrun New Material Co., Ltd from Li Yunkai, Lai Anping, Yang Yifeng and Liu Haijun for CNY 19.6 million. Hunan Sokan New Materials Co., Ltd. (SHSE:688157) agreed to acquire 20% stake in Changsha Songrun New Material Co., Ltd from Li Yunkai, Lai Anping, Yang Yifeng and Liu Haijun for CNY 19.6 million on March 26, 2024. After the transaction, Hunan Sokan’s stake in Changsha Songrun will increase from 80% to 100%. Changsha Songrun will use its own funds for the acquisition. Changsha Songrun reported total assets of CNY 58.4 million, net assets of CNY -1.3 million, revenues of CNY 66 million and net loss of CNY 0.03 million as of December 31, 2023. The board of directors of Hunan Sokan approved the transaction. Annuncio • Feb 22
Hunan Sokan New Materials Co., Ltd. (SHSE:688157) announces an Equity Buyback for CNY 30 million worth of its shares. Hunan Sokan New Materials Co., Ltd. (SHSE:688157) announces a share repurchase program. Under the program, the company will repurchase up to CNY 30 million worth of its shares. The shares will be repurchased at a price not more than CNY 59.27 per share. The repurchased shares will be used for Employees’ shareholding plan or equity incentive plan. The authorization will be valid for a period of 12 months. Valuation Update With 7 Day Price Move • Feb 13
Investor sentiment improves as stock rises 28% After last week's 28% share price gain to CN¥38.54, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 44% over the past three years. Reported Earnings • Feb 07
Full year 2023 earnings released: EPS: CN¥0.75 (vs CN¥0.75 in FY 2022) Full year 2023 results: EPS: CN¥0.75 (in line with FY 2022). Revenue: CN¥588.2m (up 18% from FY 2022). Net income: CN¥83.3m (up 1.3% from FY 2022). Profit margin: 14% (down from 17% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 34% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 23% per year, which means it is performing significantly worse than earnings. New Risk • Feb 07
New major risk - Revenue and earnings growth Earnings have declined by 1.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. New Risk • Feb 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (24% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.7% average weekly change). Valuation Update With 7 Day Price Move • Jan 23
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥41.01, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 41% over the past three years. Reported Earnings • Nov 02
Third quarter 2023 earnings released: EPS: CN¥0.24 (vs CN¥0.23 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.24 (up from CN¥0.23 in 3Q 2022). Revenue: CN¥169.3m (up 22% from 3Q 2022). Net income: CN¥26.9m (up 6.7% from 3Q 2022). Profit margin: 16% (down from 18% in 3Q 2022). Revenue is forecast to grow 40% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 14% per year whereas the company’s share price has fallen by 12% per year. Reported Earnings • Aug 18
Second quarter 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.17 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.20 (up from CN¥0.17 in 2Q 2022). Revenue: CN¥151.7m (up 15% from 2Q 2022). Net income: CN¥23.7m (up 27% from 2Q 2022). Profit margin: 16% (up from 14% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 34% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Annuncio • Jun 28
Hunan Sokan New Materials Co., Ltd. to Report First Half, 2023 Results on Aug 18, 2023 Hunan Sokan New Materials Co., Ltd. announced that they will report first half, 2023 results on Aug 18, 2023 Price Target Changed • May 20
Price target decreased by 13% to CN¥118 Down from CN¥136, the current price target is an average from 2 analysts. New target price is 68% above last closing price of CN¥70.00. Stock is down 14% over the past year. The company is forecast to post earnings per share of CN¥1.33 for next year compared to CN¥1.05 last year. Major Estimate Revision • May 13
Consensus revenue estimates increase by 11% The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from CN¥605.0m to CN¥669.5m. EPS estimate unchanged at CN¥1.27. Net income forecast to grow 71% next year vs 54% growth forecast for Chemicals industry in China. Consensus price target of CN¥128 unchanged from last update. Share price fell 4.7% to CN¥72.88 over the past week. Price Target Changed • Apr 25
Price target increased by 12% to CN¥153 Up from CN¥136, the current price target is provided by 1 analyst. New target price is 99% above last closing price of CN¥76.81. Stock is up 1.3% over the past year. The company is forecast to post earnings per share of CN¥1.70 for next year compared to CN¥1.05 last year. Reported Earnings • Apr 18
First quarter 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.25 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.04 (down from CN¥0.25 in 1Q 2022). Revenue: CN¥94.2m (down 20% from 1Q 2022). Net income: CN¥3.03m (down 85% from 1Q 2022). Profit margin: 3.2% (down from 17% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 38% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Reported Earnings • Feb 12
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: CN¥1.03 (down from CN¥1.24 in FY 2021). Revenue: CN¥508.0m (flat on FY 2021). Net income: CN¥81.9m (down 16% from FY 2021). Profit margin: 16% (down from 19% in FY 2021). Revenue missed analyst estimates by 4.6%. Earnings per share (EPS) also missed analyst estimates by 32%. Revenue is forecast to grow 29% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Hui Shen was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 28
Third quarter 2022 earnings released: EPS: CN¥0.32 (vs CN¥0.32 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.32 (in line with 3Q 2021). Revenue: CN¥139.2m (up 2.9% from 3Q 2021). Net income: CN¥25.2m (flat on 3Q 2021). Profit margin: 18% (in line with 3Q 2021). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Reported Earnings • Sep 02
Second quarter 2022 earnings released: EPS: CN¥0.24 (vs CN¥0.29 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.24 (down from CN¥0.29 in 2Q 2021). Revenue: CN¥131.9m (up 9.7% from 2Q 2021). Net income: CN¥18.7m (down 21% from 2Q 2021). Profit margin: 14% (down from 20% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 35%, compared to a 33% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Jun 02
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥89.78, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 16% over the past year. Reported Earnings • May 02
First quarter 2022 earnings: EPS misses analyst expectations First quarter 2022 results: EPS: CN¥0.25 (down from CN¥0.29 in 1Q 2021). Revenue: CN¥117.0m (up 4.3% from 1Q 2021). Net income: CN¥20.0m (down 12% from 1Q 2021). Profit margin: 17% (down from 20% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 15%. Over the next year, revenue is forecast to grow 32%, compared to a 42% growth forecast for the industry in China. Board Change • Apr 27
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Hui Shen was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Board Change • Mar 23
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Hui Shen was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Reported Earnings • Mar 01
Full year 2021 earnings: EPS misses analyst expectations Full year 2021 results: EPS: CN¥1.24 (down from CN¥1.26 in FY 2020). Revenue: CN¥508.2m (up 17% from FY 2020). Net income: CN¥97.4m (up 12% from FY 2020). Profit margin: 19% (in line with FY 2020). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 15%. Over the next year, revenue is forecast to grow 25%, compared to a 47% growth forecast for the industry in China. Reported Earnings • Oct 31
Third quarter 2021 earnings released: EPS CN¥0.32 (vs CN¥0.32 in 3Q 2020) The company reported a mediocre third quarter result with weaker profit margins, although earnings were flat and revenues improved. Third quarter 2021 results: Revenue: CN¥135.3m (up 15% from 3Q 2020). Net income: CN¥25.3m (flat on 3Q 2020). Profit margin: 19% (down from 22% in 3Q 2020). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • Sep 02
Investor sentiment deteriorated over the past week After last week's 23% share price decline to CN¥94.21, the stock trades at a forward P/E ratio of 52x. Average forward P/E is 20x in the Chemicals industry in China. Total loss to shareholders of 17% over the past year. Reported Earnings • Aug 27
Second quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.32 in 2Q 2020) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥120.2m (up 1.9% from 2Q 2020). Net income: CN¥23.7m (down 6.2% from 2Q 2020). Profit margin: 20% (down from 21% in 2Q 2020). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • May 11
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥92.90, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 18x in the Chemicals industry in China. Reported Earnings • May 02
Full year 2020 earnings released: EPS CN¥1.26 (vs CN¥1.56 in FY 2019) The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CN¥434.9m (down 4.4% from FY 2019). Net income: CN¥87.2m (down 6.1% from FY 2019). Profit margin: 20% (in line with FY 2019). Analyst Estimate Surprise Post Earnings • Jan 19
Revenue and earnings miss expectations Revenue missed analyst estimates by 17%. Earnings per share (EPS) also missed analyst estimates by 23%. Over the next year, revenue is forecast to grow 65%, compared to a 48% growth forecast for the Chemicals industry in China. Reported Earnings • Jan 16
Full year 2020 earnings released: EPS CN¥1.20 The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥435.4m (down 4.3% from FY 2019). Net income: CN¥79.3m (down 15% from FY 2019). Profit margin: 18% (down from 20% in FY 2019). The decrease in margin was driven by lower revenue. Analyst Estimate Surprise Post Earnings • Jan 16
Revenue and earnings miss expectations Revenue missed analyst estimates by 17%. Earnings per share (EPS) also missed analyst estimates by 23%. Over the next year, revenue is forecast to grow 65%, compared to a 49% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Jan 04
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥91.25, the stock is trading at a trailing P/E ratio of 63.4x, up from the previous P/E ratio of 54.4x. This compares to an average P/E of 35x in the Chemicals industry in China. Is New 90 Day High Low • Dec 11
New 90-day low: CN¥88.19 The company is down 14% from its price of CN¥102 on 11 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥50.09 per share. Is New 90 Day High Low • Nov 25
New 90-day low: CN¥96.23 The company is down 9.0% from its price of CN¥106 on 28 August 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥43.18 per share. Annuncio • Oct 29
Hunan Sokan New Materials Co., Ltd to Report Q3, 2020 Results on Oct 30, 2020 Hunan Sokan New Materials Co., Ltd announced that they will report Q3, 2020 results on Oct 30, 2020 Is New 90 Day High Low • Oct 20
New 90-day high: CN¥121 The company is up 31% from its price of CN¥92.57 on 22 July 2020. The Chinese market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥39.34 per share. Annuncio • Jul 06
Hunan Sokan New Materials Co., Ltd. to Report First Half, 2020 Results on Aug 18, 2020 Hunan Sokan New Materials Co., Ltd. announced that they will report first half, 2020 results on Aug 18, 2020